Health Care: Drugs

Novogen Ltd (NVGN: NASDAQ)

$1.39 -0.05 | -3.47%
03/23/17 - 03:56 PM ET
Company Profile
Price and Volume
Recent Price 1.39
52 Week High 2.67
52 Week Low 1.37
Avg. Daily Vol. (Mil) 0.04
Beta (3 year) 1.09
Share Related Items
Mkt Cap (Mil) 26.87
Shares Out (Mil) 19.33
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.50
Current Ratio 9.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 88.63
Price/Book 1.17
Price/Cash Flow -3.10
Per Share Data
Earnings -0.53
Sales 0.02
Book Value 1.18
Cash Flow -0.44
Business Summary
Novogen Ltd is a pharmaceutical drug development based on a simple benzopyran chemical structure.
General Information
Level 5, 20 George Street
Hornsby, NS 2077
www.novogen.com
Industry : Drugs
Sector: Health Care
Employees: 16
CEO: Dr. James Garner,M.B.B.S.
Short Interest
Current Month (Mil) 0.01
Previous Month (Mil) 0.00
Short Interest Ratio (Days) 0.30
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NVGN

Latest NVGN Headlines from TheStreet

More Financial News for NVGN

Press Releases for NVGN

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter